These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30453499)

  • 21. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
    Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease.
    Niemuth NA; Fallacara D; Triplett CA; Tamrakar SM; Rajbhandari A; Florence C; Ward L; Griffiths A; Carrion R; Goez-Gazi Y; Alfson KJ; Staples HM; Brasel T; Comer JE; Massey S; Smith J; Kocsis A; Lowry J; Johnston SC; Nalca A; Goff AJ; Shurtleff AC; Pitt ML; Trefry J; Fay MP
    PLoS One; 2021; 16(7):e0252874. PubMed ID: 34214118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever.
    Speranza E; Bixler SL; Altamura LA; Arnold CE; Pratt WD; Taylor-Howell C; Burrows C; Aguilar W; Rossi F; Shamblin JD; Wollen SE; Zelko JM; Minogue T; Nagle E; Palacios G; Goff AJ; Connor JH
    Sci Transl Med; 2018 Mar; 10(434):. PubMed ID: 29593102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ebola Virus Makona Shows Reduced Lethality in an Immune-deficient Mouse Model.
    Smither SJ; Eastaugh L; Ngugi S; O'Brien L; Phelps A; Steward J; Lever MS
    J Infect Dis; 2016 Oct; 214(suppl 3):S268-S274. PubMed ID: 27471321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform.
    Cnops L; Van den Eede P; Pettitt J; Heyndrickx L; De Smet B; Coppens S; Andries I; Pattery T; Van Hove L; Meersseman G; Van Den Herrewegen S; Vergauwe N; Thijs R; Jahrling PB; Nauwelaers D; Ariën KK
    J Infect Dis; 2016 Oct; 214(suppl 3):S192-S202. PubMed ID: 27247341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.
    Trefry JC; Wollen SE; Nasar F; Shamblin JD; Kern SJ; Bearss JJ; Jefferson MA; Chance TB; Kugelman JR; Ladner JT; Honko AN; Kobs DJ; Wending MQ; Sabourin CL; Pratt WD; Palacios GF; Pitt ML
    Viruses; 2015 Dec; 7(12):6739-54. PubMed ID: 26703716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice.
    Zumbrun EE; Abdeltawab NF; Bloomfield HA; Chance TB; Nichols DK; Harrison PE; Kotb M; Nalca A
    Viruses; 2012 Dec; 4(12):3468-93. PubMed ID: 23207275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R
    PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
    Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed Disease in Cynomolgus Macaques Exposed to Ebola Virus by an Intranasal Route.
    Johnston SC; Wilhelmsen CL; Shamblin J; Kimmel A; Zelko J; Wollen S; Goff AJ
    Front Immunol; 2021; 12():709772. PubMed ID: 34484210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of a non-human primate model of Ebola disease: Infection of Mauritian cynomolgus macaques and analysis of virus populations.
    Piorkowski G; Jacquot F; Quérat G; Carbonnelle C; Pannetier D; Mentré F; Raoul H; de Lamballerie X
    Antiviral Res; 2017 Apr; 140():95-105. PubMed ID: 28132865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of Ebola virus from pigs to non-human primates.
    Weingartl HM; Embury-Hyatt C; Nfon C; Leung A; Smith G; Kobinger G
    Sci Rep; 2012; 2():811. PubMed ID: 23155478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques.
    Martins K; Cooper C; Warren T; Wells J; Bell T; Raymond J; Stuthman K; Benko J; Garza N; van Tongeren S; Donnelly G; Retterer C; Dong L; Bavari S
    Viral Immunol; 2015 Feb; 28(1):32-41. PubMed ID: 25514385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses.
    Frei JC; Nyakatura EK; Zak SE; Bakken RR; Chandran K; Dye JM; Lai JR
    Sci Rep; 2016 Jan; 6():19193. PubMed ID: 26758505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
    Geisbert TW; Strong JE; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.
    Wong G; Qiu X; de La Vega MA; Fernando L; Wei H; Bello A; Fausther-Bovendo H; Audet J; Kroeker A; Kozak R; Tran K; He S; Tierney K; Soule G; Moffat E; Günther S; Gao GF; Strong J; Embury-Hyatt C; Kobinger G
    J Infect Dis; 2016 Oct; 214(suppl 3):S281-S289. PubMed ID: 27651412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low potential for mechanical transmission of Ebola virus via house flies (Musca domestica).
    Haddow AD; Nasar F; Schellhase CW; Moon RD; Padilla SL; Zeng X; Wollen-Roberts SE; Shamblin JD; Grimes EC; Zelko JM; Linthicum KJ; Bavari S; Pitt ML; Trefry JC
    Parasit Vectors; 2017 May; 10(1):218. PubMed ID: 28468673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.
    Qiu X; Audet J; Wong G; Pillet S; Bello A; Cabral T; Strong JE; Plummer F; Corbett CR; Alimonti JB; Kobinger GP
    Sci Transl Med; 2012 Jun; 4(138):138ra81. PubMed ID: 22700957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.
    Reisler RB; Yu C; Donofrio MJ; Warren TK; Wells JB; Stuthman KS; Garza NL; Vantongeren SA; Donnelly GC; Kane CD; Kortepeter MG; Bavari S; Cardile AP
    Emerg Infect Dis; 2017 Aug; 23(8):1316-1324. PubMed ID: 28726603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.